BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 9515165)

  • 1. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
    Michie AM; Rena G; Harnett MM; Houslay MD
    Cell Biochem Biophys; 1998; 28(2-3):161-85. PubMed ID: 9515165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
    Bian JS; Zhang WM; Pei JM; Wong TM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways.
    Bihoreau C; Heurtier A; Enjalbert A; Corvaïa N; Bensussan A; Degos L; Kordon C
    Eur J Immunol; 1991 Nov; 21(11):2877-82. PubMed ID: 1657616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor/CD3 complex internalization following activation of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-sensitive step.
    Boyer C; Auphan N; Luton F; Malburet JM; Barad M; Bizozzero JP; Reggio H; Schmitt-Verhulst AM
    Eur J Immunol; 1991 Jul; 21(7):1623-34. PubMed ID: 1829410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
    Torphy TJ; Zhou HL; Cieslinski LB
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific CD3 epsilon association of a phosphodiesterase 4B isoform determines its selective tyrosine phosphorylation after CD3 ligation.
    Baroja ML; Cieslinski LB; Torphy TJ; Wange RL; Madrenas J
    J Immunol; 1999 Feb; 162(4):2016-23. PubMed ID: 9973473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol 4,5-bisphosphate hydrolysis accompanies T cell receptor-induced apoptosis of murine thymocytes within the thymus.
    Conroy LA; Jenkinson EJ; Owen JJ; Michell RH
    Eur J Immunol; 1995 Jul; 25(7):1828-35. PubMed ID: 7621860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram.
    Michie AM; Lobban M; Müller T; Harnett MM; Houslay MD
    Cell Signal; 1996 Feb; 8(2):97-110. PubMed ID: 8730511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction pathways involved in T cell receptor-induced regulation of CD2 avidity for CD58.
    Hahn WC; Burakoff SJ; Bierer BE
    J Immunol; 1993 Apr; 150(7):2607-19. PubMed ID: 7681075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
    Laxminarayana D; Kammer GM
    J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of IgD-receptor expression on murine T cells. II. Upregulation of IgD receptors is obtained after activation of various intracellular second-messenger systems; tyrosine kinase activity is required for the effect of IgD.
    Amin AR; Swenson CD; Xue B; Ishida Y; Nair BG; Patel TB; Chused TM; Thorbecke GJ
    Cell Immunol; 1993 Dec; 152(2):422-39. PubMed ID: 8258149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ; Liu H; Palmer D; Maurice DH
    Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.
    Foissier L; Lonchampt M; Cogé F; Canet E
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1484-90. PubMed ID: 8819536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase.
    Trevillyan JM; Lu YL; Atluru D; Phillips CA; Bjorndahl JM
    J Immunol; 1990 Nov; 145(10):3223-30. PubMed ID: 2172380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental control of T-cell receptor internalization.
    Luton F; Buferne M; Schmitt-Verhulst AM; Boyer C
    Thymus; 1994; 23(1):15-25. PubMed ID: 7863544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY; Loh HH
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C.
    Nel AE; Hanekom C; Rheeder A; Williams K; Pollack S; Katz R; Landreth GE
    J Immunol; 1990 Apr; 144(7):2683-9. PubMed ID: 2156931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.